The global public relations group of INC Research/inVentiv Health helps launch brands and build the reputations of companies working to improve human health. With an integrated approach to communications, inVentiv Health Public Relations Group includes four agencies that offer best-in-class capabilities spanning public relations, digital and social media, medical and scientific education, and analytics and measurement.
Our teams create communications that drive corporate value, enhance brand perception, and deliver on the bottom line. Agencies within inVentiv Health Public Relations Group include: Allidura Consumer, Biosector 2, Chamberlain Healthcare PR, and Chandler Chicco Agency.
inVentiv Health Public Relations Group is powered by INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization. With more than 22,000 employees and the ability to support customers in more than 110 countries, our global scale and deep therapeutic alignment enables INC Research/inVentiv Health to help customers successfully navigate an increasingly complex environment.
Allidura Consumer is a health and wellness communications agency that specializes in creating enduring alliances between brands and those that influence them. The agency specializes in integrated communications campaigns, corporate reputation management, content strategy and message development, influencer mapping and engagement, media relations and training and social media and employee engagement.
Biosector 2 (B2) is a global healthcare communications agency that partners with visionary clients to deliver groundbreaking programs and improve the health of people's lives. With a dynamic and collaborative team in New York, Washington, Los Angeles, and London, B2 provides clients with global reach and fully integrated services.
Chamberlain is a healthcare public relations company serving the healthcare sector exclusively. For more than 20 years, Chamberlain has worked to redefine and shape the standards by which health information is communicated. Chamberlain’s diverse client roster represents several sectors in healthcare - from leading Fortune 100 & 500 pharmaceutical companies, to nonprofit organizations, to biotechnology and medical organizations.
Chandler Chicco Agency (CCA) is a global team of healthcare communications specialists dedicated to helping clients solve their most complex challenges. Integrating an unmatched breadth of resources that enables a comprehensive, 360-degree approach, CCA serves clients that span the spectrum of healthcare from blockbusters to niche products; large pharma to emerging specialty companies; biotech to devices and diagnostics; healthcare technology, hospitals, non-profits and academic centers.
inVentiv Health Communications is a purpose-built collective of agencies focused on supporting health and biopharmaceutical innovators. We work in scalable, collaborative teams that partner across disciplines and geographies to deliver integrated communications strategies that accelerate brand performance. In today's fast-changing and complex environment, success lies in making connections: between science, emotion and technology; between data, design and human insight. We’re able to make those connections because our advertising, public relations, medical communications, digital, data science, research and market access specialists have the ability to tap the expertise of clinical and commercial colleagues worldwide to infuse programs with deep therapeutic and analytic insights.
inVentiv Health Communications is powered by INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization. With more than 22,000 employees and the ability to support customers in more than 110 countries, our global scale and deep therapeutic alignment enables INC Research/inVentiv Health to help customers successfully navigate an increasingly complex environment.
This edition of Med-Sci Matters includes recent promising findings with type 1 diabetes, heart disease, cancer and human “healthspan”; the cost-benefit battle with a PCSK9 inhibitor; questions about the rigor of FDA accelerated approvals;…
TWTW team took some time out of our Monday schedules to pass around a pair of eclipse glasses and soak up the (lack of) sun. We were in good company at New York City’s Highline and across the country. Eclipse watching on Monday incurred a drop…
Like the rest of the nation, The Week That Was is feeling somber following troubling events in the US and abroad. And, we saw American business leaders wade into the political fray. In this week’s installment, we take some time to talk about th…